|
ZNF471 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.826000E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.380500E-04 |
| Normal-vs-Stage2 |
1.155820E-01 |
| Normal-vs-Stage3 |
1.62289999994236E-07 |
| Normal-vs-Stage4 |
1.7696999998762E-07 |
| Stage1-vs-Stage2 |
7.696000E-01 |
| Stage1-vs-Stage3 |
7.260500E-03 |
| Stage1-vs-Stage4 |
6.756800E-03 |
| Stage2-vs-Stage3 |
2.999400E-01 |
| Stage2-vs-Stage4 |
1.611030E-01 |
| Stage3-vs-Stage4 |
5.046200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.967400E-04 |
| Normal-vs-AfricanAmerican |
3.858200E-02 |
| Normal-vs-Asian |
9.834000E-04 |
| Caucasian-vs-AfricanAmerican |
6.780200E-01 |
| Caucasian-vs-Asian |
4.834400E-01 |
| AfricanAmerican-vs-Asian |
3.619000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.384600E-04 |
| Normal-vs-Female |
2.028000E-02 |
| Male-vs-Female |
8.139000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.056000E-02 |
| Normal-vs-Extreme_Weight |
1.034010E-04 |
| Normal-vs-Obese |
6.890200E-02 |
| Normal-vs-Extreme_Obese |
2.309400E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.192000E-01 |
| Normal_Weight-vs-Obese |
8.533200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.399200E-01 |
| Extreme_Weight-vs-Obese |
3.308200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.003600E-01 |
| Obese-vs-Extreme_Obese |
8.689800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.540600E-01 |
| Normal-vs-Age(41-60Yrs) |
6.659000E-03 |
| Normal-vs-Age(61-80Yrs) |
2.623900E-03 |
| Normal-vs-Age(81-100Yrs) |
2.357800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.176000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.064200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.075000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.995400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.052600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.417800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.477000E-01 |
| Normal-VS-Type2 PRCC |
1.17683640610267E-14 |
| Normal-VS-KIRP CIMP |
6.110600E-01 |
| Normal-VS-Unclassified PRCC |
1.424300E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.90114590736812E-12 |
| Type1 PRCC-VS-KIRP CIMP |
9.298400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.278400E-03 |
| Type2 PRCC-VS-KIRP CIMP |
1.856060E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.647900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.816400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.600600E-04 |
| Normal-vs-N1 |
4.961200E-04 |
| Normal-vs-N2 |
5.032200E-04 |
| N0-vs-N1 |
5.795200E-01 |
| N0-vs-N2 |
5.201400E-01 |
| N1-vs-N2 |
6.681800E-01 |
|
|
